Live feed07:00:00·4mPRReleasevia QuantisnowCervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042ByQuantisnow·Wall Street's wire, on your screen.CRVO· CervoMed Inc.Health Care
